JP2004002429A5 - - Google Patents

Info

Publication number

JP2004002429A5

JP2004002429A5 JP2003152738A JP2003152738A JP2004002429A5 JP 2004002429 A5 JP2004002429 A5 JP 2004002429A5 JP 2003152738 A JP2003152738 A JP 2003152738A JP 2003152738 A JP2003152738 A JP 2003152738A JP 2004002429 A5 JP2004002429 A5 JP 2004002429A5

Authority

JP

Japan

Prior art keywords

composition according

chamomile

medicament

manufacture

active ingredient

Prior art date

2003-05-29

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 description 14
• 240000003538 Chamaemelum nobile Species 0.000 description 11
• 235000007866 Chamaemelum nobile Nutrition 0.000 description 11
• 235000007232 Matricaria chamomilla Nutrition 0.000 description 11
• 239000003814 drug Substances 0.000 description 11
• 238000004519 manufacturing process Methods 0.000 description 11
• 239000004480 active ingredient Substances 0.000 description 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
• 201000010099 disease Diseases 0.000 description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
• 239000006286 aqueous extract Substances 0.000 description 5
• 102000004877 Insulin Human genes 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 229940125396 insulin Drugs 0.000 description 3
• 208000030507 AIDS Diseases 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 241000711573 Coronaviridae Species 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 241000721454 Pemphigus Species 0.000 description 2
• 201000004681 Psoriasis Diseases 0.000 description 2
• 206010039710 Scleroderma Diseases 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 229910021645 metal ion Inorganic materials 0.000 description 2
• 208000017520 skin disease Diseases 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 102000018997 Growth Hormone Human genes 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
• 208000027954 Poultry disease Diseases 0.000 description 1
• GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 229930003270 Vitamin B Natural products 0.000 description 1
• 229930003268 Vitamin C Natural products 0.000 description 1
• 230000001387 anti-histamine Effects 0.000 description 1
• 239000000739 antihistaminic agent Substances 0.000 description 1
• KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical group C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
• 229940117893 apigenin Drugs 0.000 description 1
• XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
• 235000008714 apigenin Nutrition 0.000 description 1
• 229910001424 calcium ion Inorganic materials 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000019156 vitamin B Nutrition 0.000 description 1
• 239000011720 vitamin B Substances 0.000 description 1
• 235000010374 vitamin B1 Nutrition 0.000 description 1
• 239000011691 vitamin B1 Substances 0.000 description 1
• 235000019154 vitamin C Nutrition 0.000 description 1
• 239000011718 vitamin C Substances 0.000 description 1
• 150000003722 vitamin derivatives Chemical class 0.000 description 1